Use of autologous chondrocytes and bioinert perforated chambers to tissue engineer cartilage in vivo

J Surg Res. 2012 Mar;173(1):e27-32. doi: 10.1016/j.jss.2011.09.041. Epub 2011 Oct 12.

Abstract

Objective: To explore the potential applications of a chamber for in vivo tissue engineering, and to establish a novel model for in vivo tissue-engineered cartilage.

Methods: Four experimental groups were included in this study: (A) chambers + chondrocytes/collagen gel; (B) chambers + chondrocytes/PLGA gel; (C) chondrocytes/collagen gel alone; and (D) chondrocytes/PLGA gel alone. Groups C and D served as controls. The samples were implanted subcutaneously in the donor rabbit, and the contents were harvested at 8 wk after implantation.

Results: Histologic and immunohistochemical staining and RT-PCR results revealed regenerated cartilage-like tissue in group B and small, irregularly shaped islands of opalescent tissue in group A. In contrast, the control groups displayed vascular invasion and inflammatory reaction, which eventually led to fibrosis and absorption.

Conclusions: Reproduced cartilages were obtained in an immunocompetent animal model through the use of a bioinert perforated chamber.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cartilage / cytology*
  • Cartilage / metabolism
  • Cell Proliferation*
  • Chondrocytes / cytology*
  • Chondrocytes / metabolism
  • Collagen / metabolism
  • Gels / metabolism
  • Lactic Acid / metabolism
  • Male
  • Models, Animal
  • Polyglycolic Acid / metabolism
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Rabbits
  • Tissue Engineering / instrumentation*
  • Tissue Engineering / methods*
  • Transplantation, Autologous

Substances

  • Gels
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Collagen